Evogene (EVGN) Loans - Gross (2012 - 2025)

Evogene has reported Loans - Gross for 14 years, with the latest figure at $20.0 million in Q4 2025.

• Quarterly Loans - Gross fell 49.71% year-over-year to $20.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.0 million (down 49.71% YoY) and the FY2025 annual result came in at $20.0 million, down 49.71% from the prior year.
• Loans - Gross fell to $20.0 million in Q4 2025 per EVGN's latest filing, from $20.8 million in the prior quarter.
• Over five years, Loans - Gross peaked at $92.8 million in Q1 2021 and troughed at $17.8 million in Q1 2025.
• A 5-year average of $52.3 million and a median of $52.2 million in 2023 frame the typical range for Loans - Gross.
• The sharpest annual moves came in 2021 and 2025: Loans - Gross jumped 43.52% in 2021, then tumbled 61.94% in 2025.
• Over 5 years, Loans - Gross stood at $76.3 million in 2021, then decreased by 26.44% to $56.1 million in 2022, then fell by 8.95% to $51.1 million in 2023, then fell by 21.99% to $39.9 million in 2024, then plunged by 49.71% to $20.0 million in 2025.
• According to Business Quant data, Loans - Gross over the past three periods registered $20.0 million, $20.8 million, and $28.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.